In an interview with Targeted Oncology, Hua-Jay “Jeff” Cherng, MD, assistant professor of medicine in the lymphoma program in ...

Burkitt lymphoma is a highly aggressive B-cell non-Hodgkin lymphoma whose diagnosis relies on integrated clinical, pathological, and imaging assessments. Established diagnostic criteria include ...

Hodgkin lymphoma (HL) is a treatable cancer with an incidence peak in adolescent and young adult years. Treatment strategies have been developed to balance the intensity of therapy needed to maintain ...

Stage 1 mixed cellularity Hodgkin lymphoma is often highly treatable, and many patients achieve long-term remission after frontline therapy. Advances in chemotherapy, radiation techniques and targeted ...

Friedberg noted that chemotherapy combined with an antibody remains a recommended treatment for patients with advanced-stage ...

• Cancer-related fatigue (CRF) is a prevalent issue for individuals undergoing lymphoma treatment, stemming from the cancer itself, the emotional and physical toll, and the side effects of treatment. ...

Stage 2 Hodgkin’s lymphoma is an early stage of this cancer. Healthcare professionals describe Hodgkin’s lymphoma as stage 2 when a person has cancer in two or more lymph node groups, either below or ...

The pleural effusion that was initially drained recurred after two weeks but subsequently resolved on follow‑up imaging as part of the patient’s response to chemotherapy. Repeat LDH measurement was ...

What Is Marginal Zone Lymphoma? Marginal zone lymphoma (MZL) isn’t one disease, but a group of rare, slow-growing blood cancers. They’re known as non-Hodgkin lymphomas because they start in your ...

BeOne Medicines AG (NASDAQ:ONC) is among the 12 best stocks to buy and hold for the next 2 years. On February 26, BeOne ...